This article was downloaded by: [Univ of Louisiana at Lafayette]
On: 24 December 2014, At: 19:54
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered
office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Agricultural and Biological Chemistry
Publication details, including instructions for authors and
subscription information:
Atrazine Metabolism by Nocardia:
Elucidation of Initial Pathway and
Synthesis of Potential Metabolites
M. C. Giardinaa, M. T. Giardia & G. Filacchionib
a Laboratory of Radiobiochemistry and Plant Ecophysiology,
National Research Council, Via Salaria Km 29,300 Rome, Italy
b Institute of Pharmaceutical Chemistry, University of Rome, Italy
Published online: 09 Sep 2014.
To cite this article: M. C. Giardina, M. T. Giardi & G. Filacchioni (1982) Atrazine Metabolism by
Nocardia: Elucidation of Initial Pathway and Synthesis of Potential Metabolites, Agricultural and
Biological Chemistry, 46:6, 1439-1445
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the
“Content”) contained in the publications on our platform. However, Taylor & Francis,
our agents, and our licensors make no representations or warranties whatsoever as to
the accuracy, completeness, or suitability for any purpose of the Content. Any opinions
and views expressed in this publication are the opinions and views of the authors,
and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content
should not be relied upon and should be independently verified with primary sources
of information. Taylor and Francis shall not be liable for any losses, actions, claims,
proceedings, demands, costs, expenses, damages, and other liabilities whatsoever
or howsoever caused arising directly or indirectly in connection with, in relation to or
arising out of the use of the Content.
This article may be used for research, teaching, and private study purposes. Any
substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,
systematic supply, or distribution in any form to anyone is expressly forbidden. Terms &